金陵药业股份有限公司2018年度财务报表分析报告Word格式.docx

1、3.3.1 资产经营盈利能力分析133.3.2 资本经营盈利能力分析133.3.3 商品经营盈利能力分析133.3.4 盈利质量分析143.4 发展能力分析143.4.1 资产资本成长分析143.4.2 营业收益成长分析143.4.3 每股净资产分析144 杜邦分析4.1 杜邦分析表154.2 杜邦分析图151 Financial Statement DataBlance Sheets1Income Sheets2Cash Flow Sheets3Changes in Owners Equity Sheets42 Analysis of Accounting Statements Analys

2、is of Blance Sheets.4Horizontal analysis4Vertical Analysis6Analysis of Income Sheets7Horizontal analysis7Vertical Analysis8Analysis of Cash Flow Sheets.9Horizontal analysis9Vertical Analysis10Analysis of Owners Equity Sheets11Horizontal analysis11Vertical Analysis113 Financial Index AnalysisAnalysis

3、 of Solvency11Short-term Solvency.11Long-term Solvency12Analysis of Operating Capability12Current Assets12Fixed Assets13Total Assets13Analysis of Profitability13Profitability of Assets13Profitability of Capital13Profitability of Goods13Profit Quality14Analysis of Growth Ability14Capital Asset Growth

4、14Income Growth.14Net Assets per Share144 Du Pont AnalysisDuPont Analysis Table15DuPont Analysis Chart151财务报表数据1.1资产负债表表格12016-2018年度 资产负债表项目（万元）Table 1Balance Sheets for 2016-20182016 年2017 年2018 年货币资金75,612.7290,754.4196,554.48交易性金融资产4,149.756,675.785,244.84应收票据净额21,392.3811,783.7525,398.03应收账款净额6

5、1,803.9953,738.8931,553.78预付款项净额3,379.851,802.31359.09其他应收款净额1,667.771,500.26854.44存货净额41,223.1441,648.9523,654.71其他流动资产33,860.9329,408.1641,268.89流动资产合计243,090.52237,312.52224,888.25可供出售金融资产净额5,548.535,240.413,651.79长期股权投资净额4,897.005,471.637,451.22投资性房地产净额1,604.421,489.171,372.70固定资产净额98,990.9195,6

6、90.24102,838.13在建工程净额6,510.244,463.538,778.73生产性生物资产净额946.29858.13727.12无形资产净额12,601.1912,327.7716,725.54商誉净额9,380.2419,802.78长期待摊费用284.34304.12119.96递延所得税资产1,771.373,060.901,645.28其他非流动资产163.1810,098.42492.03非流动资产合计142,697.69148,384.55163,605.30资产总计385,788.22385,697.06388,493.53短期借款10,400.0013,000.

7、00-应付票据5,921.642,811.3824,061.61应付账款31,054.4330,660.52预收款项2,325.582,552.772,629.50应付职工薪酬11,691.209,890.159,726.15应交税费4,200.224,152.845,756.72应付利息14.6217.9716应付股利23.5322.01其他应付款12,045.8914,698.4518,637.21一年内到期的非流动负债164.78155.22流动负债合计77,841.8977,961.3060,811.19长期借款906.31698.47专项应付款45.00长期负债合计951.31743

8、.47递延所得税负债1,697.051,605.743,078.45非流动负债合计2,648.362,349.21负债合计80,490.2580,310.5163,889.64实收资本（或股本）50,400.00资本公积46,626.5546,299.6246,226.16盈余公积32,843.5533,582.7235,285.57未分配利润123,127.52127,533.02141,440.84其他综合收益923.97858.66329.38归属于母公司所有者权益合计253,921.61258,674.02273,681.94少数股东权益51,376.3546,712.5450,921

9、.95所有者权益合计305,297.97305,386.56324,603.91负债与所有者权益总计1.2利润表表格2 2016-2018年度 利润表Table 2 Income Sheets for 2016-2018营业总收入357,865.28319,181.19289,907.91营业收入营业总成本331,383.69302,611.28269,019.47营业成本284,493.34248,426.34220,275.81营业税金及附加1,827.641,790.742,108.46销售费用13,155.3516,619.4916,400.37管理费用31,383.3531,438.

10、9730,647.24财务费用202.13474.16-204.06资产减值损失321.863,861.58-208.35公允价值变动收益-383.42414.95-384.58投资收益2,201.963,429.5415,047.27其中:对联营和合营企业的投资收益835.601,236.58599.66其他业务利润1,866.87831.78营业利润28,300.1222,281.2836,382.91营业外收入539.83229.61215.91营业外支出633.98689.94444.40利润总额28,205.9721,820.9536,154.42所得税费用5,972.544,527.867,266.60净利润22,233.4417,293.0928,887.82归属于母公司所有者的净利润18,015.1313,712.6524,178.69少数股东损益4,218.313,580.454,709.13基本每股收益0.00稀释每股收